Regarding HR+/HER2- disease, Guliyev et al. [27] reported lower pCR rates for patients with obesity compared to patients with a BMI < 30 kg/m2. This evidence concerns the gene ERBB2 and obesity due to melanocortin 4 receptor deficiency.